Department of Medicine at the Icahn School of Medicine at Mount Sinai

11/28/2025

Micaela Bayard, MD, discusses the potential benefits of GLP-1 receptor agonists for patients with rheumatoid arthritis who are on DMARD therapy. Learn how this emerging treatment option may help manage disease activity and improve patient outcomes.

CHICAGO — In this video interview with Healio, Micaela F. Bayard, MD, discussed the use of GLP-1 receptor agonists in treating patients with rheumatoid arthritis.

11/27/2025

We’re grateful every day for our dedicated faculty and staff, our inspiring patients, and the communities we proudly serve here at the Mount Sinai Department of Medicine. Your trust and support drive us to deliver exceptional, compassionate care. Wishing you and your loved ones a Happy Thanksgiving filled with warmth, connection, and good health.

11/26/2025

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators are launching an innovative new program to deliver medically tailored meals to people with metabolic dysfunction-associated steatotic liver disease (MASLD). The goal is to make behavioral lifestyle changes more achievable.

“Food is medicine,” says Xiaotao (Rony) Zhang, MD, PhD, who is helping design the nutrition plans. Participants will receive home-delivered meals and guidance from clinical dietitians, making healthy eating accessible and culturally tailored.

This program pairs nutrition support with new drug therapies for MASLD and its more severe form, metabolic dysfunction-associated steatohepatitis (MASH), aiming to improve liver health while addressing social and health disparities.

Click the link in the comments to learn more

11/26/2025

Thomas Marron, MD, PhD, discusses why patients with mediastinal lymph node–positive lung cancer may benefit from neoadjuvant chemoimmunotherapy. This treatment approach for stage III lung cancer could improve outcomes and provide new options for patients facing this diagnosis.

Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.

11/25/2025

Valerie Parkas, MD, shares how the Icahn School of Medicine at Mount Sinai is rethinking traditional premed pathways to help more talented students pursue careers in medicine. Through innovative options like the FlexMed program, which lets college sophomores apply early without the MCAT or standard premed coursework—and a new track designed for active-duty military personnel, Mount Sinai aims to widen the physician pipeline and build a more diverse, dynamic, and well-rounded future workforce. Learn more:

Icahn Mount Sinai rethinks premed path with flexible admissions to expand diverse, practice-ready physicians in New York City.

11/25/2025

Dr. Thomas Marron, Director of the Early Phase Trials Unit at the Tisch Cancer Institute, shares important insights on managing chemotherapy-related toxicities in patients with stage II–III lung cancer. His perspective, based on his presentation at the 43rd Annual Chemotherapy Foundation Symposium, highlights the importance of early communication, patient education, and proactive care.

Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.

11/24/2025

Yuying Luo, MD, discusses irritable bowel syndrome and why the diagnosis is so common in women.

IBS is much more common among women than other groups. Two gastroenterologists explained why.

11/24/2025

Andrew Varga, MD, explains which anti-snoring devices really work and how certain over-the-counter products can help reduce snoring.

While there are no guarantees, experts say certain over-the-counter products can help reduce how much you snore.

11/21/2025

The 2025 Moves Power Women Gala hosted by nymovesmagazine, celebrates influential women whose leadership drives meaningful change in their fields and communities.

We are proud to share that Monica Kraft, MD, has been selected as an honoree at this year’s gala. Dr. Kraft’s leadership in medicine, commitment to advancing patient care, and dedication to improving health outcomes reflect the values recognized by this event. Congratulations to Dr. Kraft and to all of this year’s honorees who are making an impact across industries and communities.

Icahn School of Medicine at Mount Sinai

11/21/2025

Clarivate has released its Highly Cited Researchers 2025 list, recognizing leading experts whose published work ranks among the most influential worldwide. This year’s analysis identified 6,868 researchers across more than 1,300 institutions whose contributions demonstrate meaningful, global impact in their fields.

We are proud to congratulate the Mount Sinai Department of Medicine researchers named to the 2025 Highly Cited Researchers list. Their commitment to advancing scientific discovery continues to strengthen our leadership in research excellence and supports innovations that improve patient care and public health.

Learn more by clinking the link in the comments section.

11/20/2025

Jeffrey Mechanick, MD, spoke at a World Diabetes Day awareness event, emphasizing that a healthy, balanced diet can be just as effective as medication in helping manage diabetes.

Reducing stress, having adequate sleep and exercising are the other factors that are important in controlling the “chronic metabolic disease”, doctors said at the event to mark World Diabetes Day, which was observed on Friday

11/19/2025

Meena Bansal, MD, breaks down newly FDA-approved therapy options for metabolic dysfunction–associated steatohepatitis (MASH) and offers practical insights to help guide treatment decisions for patients.

Experts discuss new FDA-approved options and practical treatment decision-making